“pHGNS: A New Frontier in Sleep Surgery”
Tuesday, November 10, 2026 at 11:30am-12:30pm ET
Summary: This session will review the neurophysiologic mechanisms, pivotal clinical evidence, patient selection considerations, and programming innovations underpinning proximal hypoglossal nerve stimulation (pHGNS) as a novel therapeutic approach for obstructive sleep apnea.
Learning Outcomes – After attending this session, participants will be able to:
Describe the neurophysiologic mechanisms and upper airway muscle recruitment patterns underlying proximal hypoglossal nerve stimulation (pHGNS).
Review clinical evidence supporting pHGNS, including outcomes from the OSPREY randomized clinical trial and emerging data on PolySync programming.
Evaluate patient selection considerations for pHGNS
Discuss high-level workflows around device activation, programming and optimizing therapeutic response to pHGNS
Speakers:
Robyn van Poelgeest, MD, PhD
Senior Director, OSA Medical Affairs at LivaNova
Ofer Jacobowitz, MD, PhD, FAASM
Co-Director of Sleep at ENT and Allergy Associates
Clinical Professor of Otolaryngology, Donald & Barbara Zucker School of Medicine
The SRS and the SRSF do not endorse any products discussed in this session.
Complimentary, Advanced Registration is Required. A recording of the webinar will be available at a later date.
